Sarode Anuja L, Su Emily, Drost Jennifer, Evan Madeline, Haselton Lyn, Blecker Nathan
Summa Health System, Surgical Services and Trauma Center, Akron, OH 44304, USA.
Summa Health System, Senior Services, Complex Care Services, Akron. OH 44304, USA.
Injury. 2025 Oct;56(10):112615. doi: 10.1016/j.injury.2025.112615. Epub 2025 Jul 15.
To assess the economic burden of hip fracture hospitalizations associated with mental health and substance use (MHSU) disorder.
We retrospectively analyzed the National Inpatient Sample 2016-2020. Patients 65 years and older with hip fracture-related ICD-10 diagnosis and discharge codes were selected. Pre-defined by Clinical Classification Software (CCS), we identified 34 MHSU groups. We analyzed MHSU disorders in two ways: first, we looked at patients with at least one MHSU disorder to compare demographic and clinical characteristics; and second, we examined individual MHSU categories separately to assess their prevalence and compare costs. The dependent variable was the hospitalization cost adjusted for 2024 inflation. Multiple regression analysis with a log transformation of costs was used to assess hospitalization costs by individual MHSU categories, adjusting for confounding factors.
Of 274,784 inpatient hip fracture admissions, 35 % had at least one diagnosis related to MHSU. Among the 34 MHSU categories, only five had a prevalence greater than 1 %: depression (15 %), anxiety or fear-related disorders (14 %), alcohol use (3 %), opioid use (3 %), and tobacco use (9 %). Patients with MHSU were younger and had longer hospital length of stay (LOS) than patients with no MHSU (NoMHSU) (median age 80 vs. 84 years, p < 0.001; median LOS 5 days vs. 4 days, p < 0.001). The total estimated cost of hospitalization for the cohort was $30.5 billion during the study period. Patients with MHSU incurred higher mean hospitalization costs compared to NoMHSU ($22,634 vs. $22,000, p < 0.001). After adjusting for demographic, regional, and clinical factors, costs were 4 % (p < 0.001) and 6 % higher (p < 0.001) for patients with alcohol-related and opioid-related disorders, respectively, compared to those without these conditions.
The economic burden of hip fractures in older adults is significant and exacerbated by the presence of substance use disorders, particularly alcohol- and opioid-related, underscoring the need for targeted policies and clinical interventions to optimize care and resource allocation for this population.
评估与心理健康和物质使用(MHSU)障碍相关的髋部骨折住院的经济负担。
我们回顾性分析了2016 - 2020年全国住院患者样本。选择年龄在65岁及以上且有与髋部骨折相关的ICD - 10诊断和出院编码的患者。根据临床分类软件(CCS)预先定义,我们确定了34个MHSU组。我们以两种方式分析MHSU障碍:第一,我们观察至少有一种MHSU障碍的患者,以比较人口统计学和临床特征;第二,我们分别检查各个MHSU类别,以评估其患病率并比较成本。因变量是根据2024年通货膨胀调整后的住院费用。使用对成本进行对数转换的多元回归分析来评估各个MHSU类别的住院费用,并对混杂因素进行调整。
在274,784例髋部骨折住院患者中,35%至少有一项与MHSU相关的诊断。在34个MHSU类别中,只有五个患病率超过1%:抑郁症(15%)、焦虑或恐惧相关障碍(14%)、酒精使用(3%)、阿片类药物使用(3%)和烟草使用(9%)。与无MHSU(NoMHSU)的患者相比,有MHSU的患者更年轻,住院时间更长(LOS)(中位年龄80岁对84岁,p < 0.001;中位LOS 5天对4天,p < 0.001)。在研究期间,该队列的住院总估计费用为305亿美元。与NoMHSU患者相比,有MHSU的患者平均住院费用更高(22,634美元对22,000美元,p < 0.001)。在调整了人口统计学、地区和临床因素后,可以发现患有酒精相关和阿片类药物相关障碍的患者的费用分别比没有这些疾病的患者高4%(p < 0.001)和6%(p < 0.001)。
老年人髋部骨折的经济负担很重,物质使用障碍的存在会加剧这种负担,特别是与酒精和阿片类药物相关的障碍,这突出表明需要制定针对性政策和临床干预措施,以优化对该人群的护理和资源分配。